Selicrelumab is an agonistic antibody targeting CD40, known to modulate the tumor microenvironment significantly. This antibody is specifically designed for use in research focused on pancreatic cancer and neoadjuvant therapies. Selicrelumab facilitates the study of CD40's role in oncologic pathways and immune responses, making it a valuable tool for advancing cancer treatment modalities.
Selicrelumab is an agonistic antibody targeting CD40, known to modulate the tumor microenvironment significantly. This antibody is specifically designed for use in research focused on pancreatic cancer and neoadjuvant therapies. Selicrelumab facilitates the study of CD40's role in oncologic pathways and immune responses, making it a valuable tool for advancing cancer treatment modalities.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
